Stephen J. Zoog

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

Paula Kaplan‐Lefko, Jonathan D. Graves, Stephen J. Zoog et al. · Cancer Biology & Therapy · 2010 · 126 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Strategy to detect pre-existing immunity to AAV gene therapy

Lillian Falese, Krystal Sandza, Bridget Yates et al. · Gene Therapy · 2017 · 99 citations · Full text

Life Sciences, Hematology, Immunology +13

Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo

Stephen J. Zoog, Jennifer Schiller, Justin Wetter et al. · The EMBO Journal · 2002 · 89 citations

Life Sciences, Immunology, Apoptosis +11

The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy

Brian Long, Krystal Sandza, Jennifer Holcomb et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 76 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian Long, P. Véron, Klaudia Kuranda et al. · Molecular Therapy · 2020 · 73 citations · Full text

Medicine, Hematology, Immunology +11